Form D — Monocacy Therapeutics Inc.
0002137361-26-000004 · filed Aug 28, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $150,000
- Total sold
- $150,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Monocacy Therapeutics Inc.
- CIK
- 2137361
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 4716 MONROVIA BLVD
MONROVIA, MD 21770 - Phone
- 3019790911
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Suman Vodnala · Executive OfficerAlameda, CA Find on LinkedIn ↗
-
Shashank Patel · Executive OfficerMonrovia, MD Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗